| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.97 |
| Hemodialysis |
0 |
0.95 |
| Dialysis |
0 |
0.98 |
| Anemia of Chronic Kidney Disease |
0 |
0.99 |
| Anemia |
0 |
0.41 |
| Cancer |
0 |
0.27 |
| Renal Disease |
0 |
0.19 |
| Kidney |
0 |
0.18 |
| Kidney, Ureter, and Bladder |
0 |
0.18 |
| Thromboembolism |
0 |
0.16 |
| Health Care Reform |
0 |
0.15 |
| Thrombosis |
0 |
0.14 |
| Esophagus |
0 |
0.09 |
| Health Care Quality, Access, and Evaluation |
0 |
0.09 |
| Hemoglobin |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Indiana |
0 |
0.09 |
| Outpatient Clinic |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Seizure |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Adverse Effects |
0 |
0.05 |
| Angiogenesis |
0 |
0.05 |
| Brachial |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Hypoxia |
0 |
0.05 |
| Meta-Analysis |
0 |
0.05 |
| Nightmares |
0 |
0.05 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.05 |
| Overdose |
0 |
0.05 |
| Addiction |
0 |
0.04 |
| Sleep Disorders |
0 |
0.04 |